Your Web Site
Provectus Lead Investigator Professor John F. Thompson to Present at Clinical Oncological Society...
KNOXVILLE, Tenn.----Provectus Pharmaceuticals, Inc. , development-stage oncology and dermatology biopharmaceutical company, announced that the lead investigator for its Phase 2 melanoma study, Professor John F.

